Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Lantern Pharma Inc. (LTRN) Q2 2026 Earnings Call Transcript
Lantern Pharma Inc. (LTRN) Q2 2026 Earnings Call August 14, 2026 9:00 AM EDT Panna Sharma - President, CEO & Director David Margrave - CFO & Secretary Good morning and welcome to our Second Quarter 2026 Earnings call. As a reminder, this call is…
Serendipity Space Successfully Demonstrates Drug Crystallisation In Near-Space For Pharma Manufacturing
Odisha-based Serendipity Space has achieved a significant milestone by successfully demonstrating drug crystallisation in a near-space mission, paving the way for advanced pharmaceutical manufacturing in low Earth orbit. Odisha-based Serendipity…
Avalyn Pharma (NASDAQ:AVLN) Cut to Sell at Wall Street Zen
Avalyn Pharma (NASDAQ:AVLN - Get Free Report) was downgraded by research analysts at Wall Street Zen from a 'hold' rating to a 'sell' rating in a research report issued to clients and investors on Saturday. A number of other brokerages have also…
Ascendis Pharma A/S (NASDAQ:ASND) Upgraded at Wall Street Zen
Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report) was upgraded by stock analysts at Wall Street Zen from a 'hold' rating to a 'buy' rating in a research note issued to investors on Saturday. Can BioMarin Stock Live Up to Wall Street's High…
California State Teachers Retirement System Grows Stock Holdings in Urogen Pharma $URGN
California State Teachers Retirement System grew its position in shares of Urogen Pharma (NASDAQ:URGN - Free Report) by 1,605.5% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange…
Spyglass Pharma (NASDAQ:SGP) Upgraded to 'Moderate Buy' at Raymond James Financial
Spyglass Pharma (NASDAQ:SGP - Get Free Report) was upgraded by Raymond James Financial to a 'moderate buy' rating in a research note issued to investors on Friday, Zacks.com reports. Separately, Weiss Ratings initiated coverage on shares of…
NervGen Pharma (NASDAQ:NGEN) Stock Rating Lowered by Wall Street Zen
NervGen Pharma (NASDAQ:NGEN - Get Free Report) was downgraded by investment analysts at Wall Street Zen from a 'hold' rating to a 'strong sell' rating in a research note issued to investors on Saturday. Other equities analysts have also recently…
Zealand Pharma A/S (OTCMKTS:ZLDPF) Lowered to 'Strong Sell' Rating by Zacks Research
Zealand Pharma A/S (OTCMKTS:ZLDPF - Get Free Report) was downgraded by investment analysts at Zacks Research from a 'hold' rating to a 'strong sell' rating in a report released on Thursday, Zacks.com reports. Several other equities analysts have…
Nuvectis Pharma (NASDAQ:NVCT) Shares Gap Up - What's Next?
Nuvectis Pharma, Inc. (NASDAQ:NVCT - Get Free Report)'s stock price gapped up before the market opened on Friday. The stock had previously closed at $19.23, but opened at $20.30. Nuvectis Pharma shares last traded at $19.1150, with a volume of…
Assenagon Asset Management S.A. Has $1.16 Million Holdings in BridgeBio Pharma, Inc. $BBIO
Assenagon Asset Management S.A. lowered its position in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 64.6% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 15,620 shares of the company's…
Health Care Down on Growth Doubts - Health Care Roundup
Health-care companies fell amid doubts about the growth outlook for the sector. Pfizer shares were more or less flat after Albert Bourla, chief executive of the Big Pharma company, bought $1 million worth of shares, the latest major insider…
Czech Tour: Netcompany Ineos dominate stage 2 to deliver AJ August to mountaintop victory and race lead
AJ August capitalised on a strong Netcompany Ineos team effort to soar to victory and into the race lead on stage 2 of the Czech Tour, finishing atop a 15km climb to Ještěd. Ineos had paced for almost all of the long final climb, with…
BridgeBio Stock Has Soared 29% in Just 3 Months. Here's Why Wall Street Thinks It Could Go Even Higher.
One of the more high-flying stocks in the U.S. biotech sector these days is genetic-disease-focused BridgeBio Pharma (BBIO -1.81%). That's due almost entirely to the outperformance of its Attruby heart medication. If the generally bullish analyst…
Former Everett Pfizer facility finds new buyer
EVERETT — Two years after Pfizer announced plans to “wind down construction” at a huge manufacturing facility in south Everett, a global life science real estate developer has acquired and leased the property to a biopharma…
Junk Food & Prostate Cancer; 'Office' Star's Stage IV Diagnosis; New Cancer Cluster?
Men with a higher consumption of ultraprocessed foods had a significantly higher risk for developing prostate cancer in a large study. (Florida Atlantic University) Maura Gillison, MD, PhD, credited for proving the link between human papillomavirus…
Receive a Daily briefing on Pharma Industry News
Get Started